Virtual Incision Corp Revenue and Competitors
Estimated Revenue & Valuation
- Virtual Incision Corp's estimated annual revenue is currently $18.3M per year.
- Virtual Incision Corp's estimated revenue per employee is $251,000
Employee Data
- Virtual Incision Corp has 73 Employees.
- Virtual Incision Corp grew their employee count by 49% last year.
Virtual Incision Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.3M | 33 | 22% | N/A | N/A |
#2 | $7M | 28 | 4% | N/A | N/A |
#3 | $41.9M | 167 | 5% | N/A | N/A |
#4 | $8.5M | 34 | -11% | N/A | N/A |
#5 | $8M | 32 | 23% | N/A | N/A |
#6 | $10.8M | 43 | 5% | N/A | N/A |
#7 | $18.3M | 73 | 49% | N/A | N/A |
What Is Virtual Incision Corp?
Virtual Incision is reimagining robotic support for minimally invasive (MIS) procedures with simple innovations offering mobility, flexibility, and accessibility to provide MIS options to more patients. The company is developing the MIRA (“miniaturized in vivo robotic assistantâ€) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications. The MIRA Platform is an investigational device that is not available for sale in the United States.
keywords:N/AN/A
Total Funding
73
Number of Employees
$18.3M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Virtual Incision Corp News
Intuitive Surgical, Virtual Incision Corporation, Medrobotics Corporation, Accuray, Titan Medical, meerecompany, TransEnterix Surgical,...
FDA decision supported by an interim clinical study report on patient safety. LINCOLN, Neb.--(BUSINESS WIRE)-- Virtual Incision Corporation,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 73 | 3% | N/A |
#2 | $19.6M | 75 | 36% | N/A |
#3 | $7.6M | 76 | 7% | N/A |
#4 | $18.6M | 76 | 1% | N/A |
#5 | $18.7M | 76 | 10% | N/A |